VIVACAINE- bupivacaine hydrochloride and epinephrine bitartrate injection, solution United States - English - NLM (National Library of Medicine)

vivacaine- bupivacaine hydrochloride and epinephrine bitartrate injection, solution

septodont, inc. - bupivacaine hydrochloride anhydrous (unii: aka908p8j1) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride anhydrous 5 mg in 1 ml - vivacaine® (bupivacaine hydrochloride and epinephrine injection, usp) is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. vivacaine® is not recommended for children. vivacaine® (bupivacaine hydrochloride and epinephrine injection, usp) is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of bupivacaine solutions.

MARCAINE- bupivacaine hydrochloride and epinephrine bitartrate injection, solution United States - English - NLM (National Library of Medicine)

marcaine- bupivacaine hydrochloride and epinephrine bitartrate injection, solution

carestream health inc. - bupivacaine hydrochloride anhydrous (unii: aka908p8j1) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride anhydrous 5 mg in 1 ml - marcaine® 0.5% with epineprhine 1:200,000 is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. marcaine® 0.5% with epinephrine 1:200,000 is not recommended for children. marcaine® 0.5% with epinephrine 1:200,000, is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of bupivacaine solutions.

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, solution United States - English - NLM (National Library of Medicine)

bupivacaine hydrochloride and epinephrine injection, solution

general injectables & vaccines, inc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride anhydrous 2.5 mg in 1 ml - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block). (see warnings .) the routes of administration and indicated bupivacaine hydrochloride concentrations are: (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique ha

VIVACAINE- bupivacaine hydrochloride and epinephrine bitartrate injection, solution United States - English - NLM (National Library of Medicine)

vivacaine- bupivacaine hydrochloride and epinephrine bitartrate injection, solution

septodont inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride 5 mg in 1 ml - vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is not recommended for children. vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) solutions.

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (australia) bupivacaine hydrochloride 0.25% (50mg/20ml) injection bp vial

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 52.8 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

BUPIVACAINE HYDROCHLORIDE injection, solution United States - English - NLM (National Library of Medicine)

bupivacaine hydrochloride injection, solution

baxter healthcare corporation - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride anhydrous 7.5 mg in 1 ml - bupivacaine hydrochloride in 8.25% dextrose injection spinal is indicated for the production of subarachnoid block (spinal anesthesia). standard text books should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. bupivacaine hydrochloride in 8.25% dextrose injection spinal is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia:

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE bitartrate injection solution United States - English - NLM (National Library of Medicine)

bupivacaine hydrochloride and epinephrine bitartrate injection solution

cardinal health - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride anhydrous 2.5 mg in 1 ml

MARCAINE- bupivacaine hydrochloride and epinephrine bitartrate injection, solution United States - English - NLM (National Library of Medicine)

marcaine- bupivacaine hydrochloride and epinephrine bitartrate injection, solution

septodont, inc. - bupivacaine hydrochloride anhydrous (unii: aka908p8j1) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - marcaine® 0.5% (5 mg/ml) with epinephrine 1:200,000 injection is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. marcaine® 0.5% (5 mg/ml) with epinephrine 1:200,000 injection is not recommended for children. marcaine® 0.5% (5 mg/ml) with epinephrine 1:200,000 injection, is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of bupivacaine solutions.

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, solution United States - English - NLM (National Library of Medicine)

bupivacaine hydrochloride and epinephrine injection, solution

henry schein, inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block). (see warnings .) the routes of administration and indicated bupivacaine hydrochloride concentrations are: (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique ha

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (australia) bupivacaine hydrochloride 0.5% (50mg/10ml) injection bp ampoule

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 52.7 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.